With the development of radiomics in the field of molecular precision medicine, epidermal growth factor receptor (EGFR) gene mutation status and lymph node metastasis in NSCLC patients can also be well predicted [13–15]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.